# Hyperaldosteronism trials, no drug phase: 21 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with no drug phase for hyperaldosteronism that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting hyperaldosteronism trials with no drug phase: 21 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/hyperaldosteronism

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 21
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 21, 2026 | NCT07884955 | Comparing Inclisiran Versus Statin for Primary Aldosteronism | Third Military Medical University | Not applicable | Recruiting | Primary Aldosteronism | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07884955) |
| September 10, 2026 | NCT07814105 | \[11C\]Metomidate PET-CT vs Usual Care for People With Primary Aldosteronism: a Proof-of-concept Study | Chinese University of Hong Kong | Not applicable | Recruiting | Primary Aldosteronism | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07814105) |
| September 2, 2026 | NCT07800858 | Baxdrostat and Molecular Imaging of Adrenal Cytoreduction in Primary Aldosteronism | Queen Mary University of London | Not applicable | Not yet recruiting | Primary Aldosteronism | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800858) |
| August 31, 2026 | NCT07796048 | Regular Sauna Use to Lower Blood Pressure in Primary Aldosteronism | University of Calgary | Not applicable | Not yet recruiting | Primary Aldosteronism, Hypertension | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07796048) |
| July 14, 2026 | NCT07700472 | Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma | Chongqing Medical University | Not applicable | Not yet recruiting | Primary Aldosteronism, Aldosterone-Producing Adenoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07700472) |
| July 7, 2026 | NCT07688928 | Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism | Bangladesh Medical University | Not applicable | Recruiting | Primary Aldosteronism, Endocrine Hypertension | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07688928) |
| June 29, 2026 | NCT07673445 | Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism | Chongqing Medical University | Not applicable | Recruiting | Primary Aldosteronism | 3,830 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673445) |
| March 13, 2026 | NCT07470580 | Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension | University Hospital, Toulouse | Not applicable | Recruiting | Primary Aldosteronism Due to Conn Adenoma, Radiofrequency Ablation Treatment, Adrenalectomy | 134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470580) |
| January 9, 2026 | NCT07328230 | Superselective Adrenal Arterial Embolization Versus Oral Spironolactone for Treatment of Idiopathic Hyperaldosteronism | Chinese Academy of Medical Sciences, Fuwai Hospital | Not applicable | Recruiting | Idiopathic Hyperaldosteronism, Hyperaldosteronism | 172 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07328230) |
| December 23, 2025 | NCT07298954 | Sequential Combined Versus Single-Strategy Adrenal Venous Sampling for Primary Aldosteronism(SCOPE) | Sponsor not shown (see the record) | Not applicable | Recruiting | Primary Aldosteronism | 456 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298954) |
| December 22, 2025 | NCT07297745 | Trial of Aldosterone-hybrid SteRoid for Guiding curablE Treatment of Primary Aldosteronism (TARGET-PA) | Changi General Hospital | Not applicable | Recruiting | Hyperaldosteronism; Primary, Primary Aldosteronism Due to Aldosterone Producing Adenoma | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07297745) |
| June 18, 2025 | NCT07027254 | PETAL Trial: Impact of Gallium-68 Pentixafor PET-CT on Surgical Outcomes in Primary Aldosteronism | Seoul National University Hospital | Not applicable | Recruiting | Primary Aldosteronism, Secondary Hypertension, Aldosterone-Producing Adenoma, Idiopathic Hyperaldosteronism... | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07027254) |
| May 20, 2025 | NCT06980753 | Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal... | University of Sao Paulo General Hospital | Not applicable | Not yet recruiting | Cushing Syndrome, Primary Aldosteronism, Adrenal Insufficiency | 246 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06980753) |
| February 18, 2025 | NCT06833437 | 68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous... | Sponsor not shown (see the record) | Not applicable | Recruiting | Primary Aldosteronism, Autonomous Cortisol Secretion | 178 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06833437) |
| December 17, 2024 | NCT06737848 | The Comparison of Single Catheter and Double Catheter Adrenal Vein Sampling Methods Based on the Upper Limb Approach | Army Medical University, China | Not applicable | Not yet recruiting | Primary Aldosteronism | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06737848) |
| July 22, 2024 | NCT06513585 | Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy | Xinjiang Medical University | Not applicable | Recruiting | Primary Aldosteronism, Suprarenalectomy, Super Selective Adrenal Artery Embolization | 570 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06513585) |
| February 9, 2024 | NCT06250699 | A Single Center Randomized Controlled Study on the Promotion of Rapid Recovery | Sponsor not shown (see the record) | Not applicable | Recruiting | Nonfunctional Adrenal Cortex Adenoma, Primary Aldosteronism, Cushing Syndrome | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06250699) |
| October 31, 2023 | NCT06108427 | REnin-guided TherApy With MinEralocorticoid Receptor Antagonists in Primary Aldosteronism - Feasibility Study | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Not applicable | Recruiting | Primary Aldosteronism | 58 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06108427) |
| April 4, 2023 | NCT05797558 | Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment | Göteborg University | Not applicable | Recruiting | Primary Hyperaldosteronism Due to Adrenal Adenoma | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05797558) |
| August 15, 2022 | NCT05501080 | The Effect of SAAE on Ventricular Remodeling in PA Patients | Second Affiliated Hospital of Nanchang University | Not applicable | Recruiting | Primary Aldosteronism | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05501080) |
| May 10, 2022 | NCT05368090 | Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism | Haukeland University Hospital | Not applicable | Recruiting | Primary Aldosteronism, Aldosterone-Producing Adenoma, Hypercortisolism | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05368090) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Chongqing Medical University | 2 |
| University of Calgary | 1 |
| Third Military Medical University | 1 |
| Seoul National University Hospital | 1 |
| University of Sao Paulo General Hospital | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Chinese University of Hong Kong | 1 |
| University Hospital, Toulouse | 1 |
| Bangladesh Medical University | 1 |
| Xinjiang Medical University | 1 |
| Queen Mary University of London | 1 |
| Changi General Hospital | 1 |
| Army Medical University, China | 1 |
| Second Affiliated Hospital of Nanchang University | 1 |
| Haukeland University Hospital | 1 |
| Göteborg University | 1 |
| Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 9 |
| South Korea | 1 |
| Brazil | 1 |
| Hong Kong | 1 |
| France | 1 |
| Bangladesh | 1 |
| United Kingdom | 1 |
| Singapore | 1 |
| Norway | 1 |
| Sweden | 1 |
| Canada | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Beverage suppliers in the United States](https://specstream.ai/data/businesses/beverage-suppliers/united-states)
- [European restaurants in the United States](https://specstream.ai/data/businesses/european-restaurants/united-states)
- [Locksmiths in the United States](https://specstream.ai/data/businesses/locksmiths/united-states)
- [Research institutes in the United States](https://specstream.ai/data/businesses/research-institutes/united-states)
- [Adult education centers in the United States](https://specstream.ai/data/businesses/adult-education-centers/united-states)
- [Colleges and universities in the United States](https://specstream.ai/data/businesses/colleges-and-universities/united-states)
